BeiGene’s Tislelizumab Delivers With OS Data In Broad Gastric Cancer Population

 
• By Jessica Merrill
applause
Tislelizumab improved overall survival in gastric cancer • Source: Shutterstock

More from Anticancer

More from Therapeutic Category